APA (7th ed.) Citation

Regnier, M., Leclerc, A. S., Tenenbaum, J., Desjonqueres, M., Chavassieux, P., Fremeaux-Bacchi, V., . . . Bacchetta, J. (2025). Bone impairment in atypical hemolytic and uremic syndrome treated by long-term eculizumab. Pediatric Nephrology, 40(4), 961. https://doi.org/10.1007/s00467-024-06564-6

Chicago Style (17th ed.) Citation

Regnier, Maitena, Anne-Laure Sellier Leclerc, Julie Tenenbaum, Marine Desjonqueres, Pascale Chavassieux, Véronique Fremeaux-Bacchi, Delphine Farlay, and Justine Bacchetta. "Bone Impairment in Atypical Hemolytic and Uremic Syndrome Treated by Long-term Eculizumab." Pediatric Nephrology 40, no. 4 (2025): 961. https://doi.org/10.1007/s00467-024-06564-6.

MLA (9th ed.) Citation

Regnier, Maitena, et al. "Bone Impairment in Atypical Hemolytic and Uremic Syndrome Treated by Long-term Eculizumab." Pediatric Nephrology, vol. 40, no. 4, 2025, p. 961, https://doi.org/10.1007/s00467-024-06564-6.